Allogeneic stem cell transplantation for chronic lymphocytic leukemia: Lessons to be learned from minimal residual disease studies
Allogeneic stem cell transplantation (alloSCT) is a potentially curative treatment strategy for poor-risk chronic lymphocytic leukemia (CLL). The crucial anti-leukemic principle of alloSCT in CLL appears to be the graft-versus-leukemia effect (GVL). Evidence for GVL in CLL is particularly provided b...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
26 January 2011
|
| In: |
Blood reviews
Year: 2011, Volume: 25, Issue: 2, Pages: 91-96 |
| ISSN: | 1532-1681 |
| DOI: | 10.1016/j.blre.2011.01.001 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.blre.2011.01.001 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0268960X11000026 
|
| Author Notes: | Sebastian Böttcher, Matthias Ritgen, Peter Dreger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 180589062X | ||
| 003 | DE-627 | ||
| 005 | 20220820194816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220603s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.blre.2011.01.001 |2 doi | |
| 035 | |a (DE-627)180589062X | ||
| 035 | |a (DE-599)KXP180589062X | ||
| 035 | |a (OCoLC)1341460513 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Böttcher, Sebastian |d 1971- |e VerfasserIn |0 (DE-588)122679954 |0 (DE-627)705998363 |0 (DE-576)293377804 |4 aut | |
| 245 | 1 | 0 | |a Allogeneic stem cell transplantation for chronic lymphocytic leukemia |b Lessons to be learned from minimal residual disease studies |c Sebastian Böttcher, Matthias Ritgen, Peter Dreger |
| 264 | 1 | |c 26 January 2011 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.06.2022 | ||
| 520 | |a Allogeneic stem cell transplantation (alloSCT) is a potentially curative treatment strategy for poor-risk chronic lymphocytic leukemia (CLL). The crucial anti-leukemic principle of alloSCT in CLL appears to be the graft-versus-leukemia effect (GVL). Evidence for GVL in CLL is particularly provided by studies analysing the kinetics of minimal residual disease (MRD). The purpose of this review is to summarize the methodologies of MRD assessment, its proven benefits and its further perspectives for optimizing the outcome of transplantation. Proven value of quantitative MRD monitoring by RQ-PCR or MRD-flow consists in using it as an indicator of long-term disease control and potential cure. As MRD kinetics correlates with GVL activity, its suitability for guiding GVL-inducing immunomodulation is currently under investigation. In conclusion, quantitative MRD monitoring seems to be mandatory to assure safe and effective immunotherapy in the context of alloSCT for CLL, which should, however, be best performed within clinical studies. | ||
| 650 | 4 | |a Allogeneic stem cell transplantation | |
| 650 | 4 | |a Chronic lymphocytic leukemia | |
| 650 | 4 | |a Minimal residual disease | |
| 700 | 1 | |a Ritgen, Matthias |d 1971- |e VerfasserIn |0 (DE-588)122069749 |0 (DE-627)081718217 |0 (DE-576)293076707 |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood reviews |d Burlington, Mass. : Harcourt, 1987 |g 25(2011), 2, Seite 91-96 |h Online-Ressource |w (DE-627)320475026 |w (DE-600)2009041-9 |w (DE-576)261621130 |x 1532-1681 |7 nnas |a Allogeneic stem cell transplantation for chronic lymphocytic leukemia Lessons to be learned from minimal residual disease studies |
| 773 | 1 | 8 | |g volume:25 |g year:2011 |g number:2 |g pages:91-96 |g extent:6 |a Allogeneic stem cell transplantation for chronic lymphocytic leukemia Lessons to be learned from minimal residual disease studies |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.blre.2011.01.001 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0268960X11000026 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220603 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 3 |y j | ||
| 999 | |a KXP-PPN180589062X |e 4142852809 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"6 S."}],"id":{"eki":["180589062X"],"doi":["10.1016/j.blre.2011.01.001"]},"language":["eng"],"origin":[{"dateIssuedDisp":"26 January 2011","dateIssuedKey":"2011"}],"recId":"180589062X","name":{"displayForm":["Sebastian Böttcher, Matthias Ritgen, Peter Dreger"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Sebastian","family":"Böttcher","display":"Böttcher, Sebastian"},{"display":"Ritgen, Matthias","family":"Ritgen","given":"Matthias","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Peter","family":"Dreger","display":"Dreger, Peter"}],"relHost":[{"note":["Gesehen am 22.01.2020"],"title":[{"title":"Blood reviews","title_sort":"Blood reviews"}],"part":{"text":"25(2011), 2, Seite 91-96","pages":"91-96","issue":"2","year":"2011","volume":"25","extent":"6"},"origin":[{"publisherPlace":"Burlington, Mass.","dateIssuedDisp":"1987-","dateIssuedKey":"1987","publisher":"Harcourt"}],"pubHistory":["1.1987 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320475026","id":{"eki":["320475026"],"issn":["1532-1681"],"zdb":["2009041-9"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"disp":"Allogeneic stem cell transplantation for chronic lymphocytic leukemia Lessons to be learned from minimal residual disease studiesBlood reviews"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 03.06.2022"],"title":[{"title_sort":"Allogeneic stem cell transplantation for chronic lymphocytic leukemia","subtitle":"Lessons to be learned from minimal residual disease studies","title":"Allogeneic stem cell transplantation for chronic lymphocytic leukemia"}]} | ||
| SRT | |a BOETTCHERSALLOGENEIC2620 | ||